Leavitt Partners May 12, 2020

Salt Lake City – New analysis from Leavitt Partners and CareJourney explores ways in which accountable care organizations (ACOs) can reduce health care costs without potentially impacting their beneficiaries’ quality of care. One such opportunity for ACOs lies in switching patients to similarly effective but less-expensive medications for particular conditions. Our analysis of Medicare claims data from 2014 to 2016 indicates that switching to the least expensive drug for one cohort of patients can make a meaningful impact on total ACO cost performance.

A summary of this analysis can be found in the white paper entitled “ACOs and Age-Related Macular Degeneration (AMD): Practice Patterns Impact Savings.” In 2016, a quarter of ACOs that saved money for Medicare but did not...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ACO (Accountable Care), CMS, Govt Agencies, Health System / Hospital, Insurance, Medicare, Payment Models, Physician, Primary care, Provider, Value Based
Voices: Thomas Kim, MD, MMM, FHM, Chief Medical Officer, Sound Long-Term Care Management
New ACO model provides alternative for physicians to stay independent
New Legislation Proposes National Expansion Of Integrated Care Models
CMS launches model to increase primary care investment in Medicare
New ACO Primary Flex Model Could Increase Hospice, Palliative Care Access

Share This Article